The 36-month beta value for AGEN is also noteworthy at 1.30. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for AGEN is 396.26M, and at present, short sellers hold a 11.54% of that float. The average trading volume of AGEN on April 08, 2024 was 10.26M shares.
AGEN) stock’s latest price update
The stock price of Agenus Inc (NASDAQ: AGEN) has dropped by -0.43 compared to previous close of 0.51. Despite this, the company has seen a fall of -13.16% in its stock price over the last five trading days. The Motley Fool reported 2024-04-03 that Analyst price targets for a pair of biotech stocks suggest they can more than double your money over the next 12 months. B. Riley recently lowered expectations for Ginkgo Bioworks, but its new target still implies more than 100% upside.
AGEN’s Market Performance
AGEN’s stock has fallen by -13.16% in the past week, with a monthly drop of -28.04% and a quarterly drop of -35.15%. The volatility ratio for the week is 10.41% while the volatility levels for the last 30 days are 9.12% for Agenus Inc The simple moving average for the last 20 days is -13.41% for AGEN’s stock, with a simple moving average of -49.53% for the last 200 days.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Outperform.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on June 06, 2023 of the previous year 2023.
Robert W. Baird, on the other hand, stated in their research note that they expect to see AGEN reach a price target of $80, previously predicting the price at $60. The rating they have provided for AGEN stocks is “Outperform” according to the report published on June 06th, 2023.
H.C. Wainwright gave a rating of “Buy” to AGEN, setting the target price at $8 in the report published on February 28th of the previous year.
AGEN Trading at -22.13% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.35% of loss for the given period.
Volatility was left at 9.12%, however, over the last 30 days, the volatility rate increased by 10.41%, as shares sank -28.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.10% lower at present.
During the last 5 trading sessions, AGEN fell by -13.16%, which changed the moving average for the period of 200-days by -73.06% in comparison to the 20-day moving average, which settled at $0.5718. In addition, Agenus Inc saw -39.16% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGEN starting from ARMEN GARO H, who purchase 500,000 shares at the price of $0.65 back on Feb 15 ’24. After this action, ARMEN GARO H now owns 625,969 shares of Agenus Inc, valued at $324,050 using the latest closing price.
WIINBERG ULF, the Director of Agenus Inc, purchase 25,000 shares at $0.76 during a trade that took place back on Nov 15 ’23, which means that WIINBERG ULF is holding 124,063 shares at $19,000 based on the most recent closing price.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -1.02 for the present operating margin
- -0.13 for the gross margin
The net margin for Agenus Inc stands at -1.6. The total capital return value is set at -2.75.
Based on Agenus Inc (AGEN), the company’s capital structure generated 2.31 points at debt to capital in total, while cash flow to debt ratio is standing at -0.74. The debt to equity ratio resting at -1.77. The interest coverage ratio of the stock is -1.61.
Currently, EBITDA for the company is -146.52 million with net debt to EBITDA at -1.89. When we switch over and look at the enterprise to sales, we see a ratio of 3.1. The receivables turnover for the company is 6.05for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.44.
Conclusion
In summary, Agenus Inc (AGEN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
